Uncategorized
Senate committee adopts bill to facilitate genetically targeted drug development
The U.S. Senate Committee on Health, Education, Labor and Pensions adopted legislation today designed to speed up development of genetically targeted drugs for patients with rare and serious or life-threating conditions.The “Advancing Targeted Therapies for Rare Diseases Act of 2015” (S. 2030), sponsored by Sens. Michael Bennet, D-Colo., Richard Burr, R-N.C., Elizabeth Warren, D-Mass., and Orrin Hatch, R-Utah, will allow drug companies seeking approval of a candidate therapy to leverage data from previously approved drug applications and to maximize the use of certain scientific methods, such as surrogate endpoints, to (Read more...)